Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Cytotherapy. 2013 Nov 13;16(6):713–733. doi: 10.1016/j.jcyt.2013.10.002

Figure 1.

Figure 1

Examples of Genetic modifications that have been explored individually or in combination with the purpose of improving the function and safety of T cells. These modifications include the transgenic expression of proteins that (i) enhance T cell homing to tumor sites, (ii) provide resistance to the tumor microenvironment, (iii) improve their proliferation and persistence and (iv) enhance their safety.